This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
GlaxoSmithKline is a well-known global leader in prescription medicines, vaccines, consumer health care, and dermatology. The company’s mission statement is simple, yet ambitious: improve the quality of human life by enabling people to do more, feel better, and live longer.
To fulfill this mission, GlaxoSmithKline operates facilities that produce pharmaceutical and health care products, many of which demand precise environmental conditions. In one recent HVAC facility upgrade, where low humidity was required to ensure flawless manufacturing, GlaxoSmithKline showed that its creative ability is not limited just to medicines and consumer goods. The company installed an innovative passive dehumidification heat pipe system that brought remarkable energy savings, a quick return-on-investment (with ongoing savings) and a direct and indirect CO2 savings of 164 metric tons/yr.